Clinical Trial to Evaluate the Efficacy and Safety of Nexpowder™ for Diverticular Bleeding in the Lower Gastrointestinal Tract

Nextbiomedical

Status: Begins enrollment this month

Conditions: Lower Gastrointestinal Bleeding; Diverticular Bleeding

Treatments: Device: Nexpowder™

Study type: Interventional

Funder types: Industry

Identifiers

NCT06939907

Nexpowder_008

Details and patient eligibility

About

Clinical Trial to Evaluate the Efficacy and Safety of Nexpowder™ for Diverticular Bleeding in the Lower Gastrointestinal Tract

Enrollment: 60 estimated patients

Sex: All

Ages: 19+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adults aged 19 years or older at the time of screening
• Patients diagnosed with diverticular bleeding

Exclusion criteria

• Patients diagnosed with upper gastrointestinal bleeding

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

60 participants in 1 patient group

Nexpowder Treatment Arm

Experimental group

Treatment:

Device: Nexpowder™